快而精医药(QGEN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

QGEN 快而精医药

未开盘 07-23 16:00:00 EDT

41.45

+0.88

+2.17%

盘后41.45

+0.000.00%

19:34 EDT

最高41.66	最低40.51	成交量272.56万
今开40.52	昨收40.57	日振幅2.82%
总市值85.39亿	流通市值85.28亿	总股本2.06亿
成交额1.13亿	换手率1.32%	流通股本2.06亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"QGEN","market":"US","secType":"STK","nameCN":"快而精医药","latestPrice":41.45,"timestamp":1784836800000,"preClose":40.57,"halted":0,"volume":2725564,"hourTrading":{"tag":"盘后","latestPrice":41.45,"preClose":41.45,"latestTime":"19:34 EDT","volume":414566,"amount":17183765.62,"timestamp":1784849651147,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.02169090460931729,"floatShares":205741367,"shares":205998950,"eps":1.940071,"marketStatus":"未开盘","change":0.88,"latestTime":"07-23 16:00:00 EDT","open":40.52,"high":41.655,"low":40.51,"amount":112636366.228652,"amplitude":0.028223,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.940071,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1784880000000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":40.57,"dividendRate":0.00635,"preHourTrading":{"tag":"盘前","latestPrice":40.49,"preClose":40.57,"latestTime":"09:29 EDT","volume":25556,"amount":1029170.6338640001,"timestamp":1784813399999,"change":-0.08,"changeRate":-0.001972,"amplitude":0.013557},"postHourTrading":{"tag":"盘后","latestPrice":41.45,"preClose":41.45,"latestTime":"19:34 EDT","volume":414566,"amount":17183765.62,"timestamp":1784849651147,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.233973,"impliedVol":0.5387,"impliedVolPercentile":0.82},"requestUrl":"/m/hq/s/QGEN","defaultTab":"news","newsList":[{"id":"1175379412","title":"异动解读｜快而精医药盘中上涨12.83%，多家私募巨头传出收购意向","url":"https://stock-news.laohu8.com/highlight/detail?id=1175379412","media":"行情直击","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175379412?lang=zh_cn&edition=full","pubTime":"2026-07-09 23:00","pubTimestamp":1783609235,"startTime":"0","endTime":"0","summary":"7月9日，快而精医药盘中上涨12.83%，报42.875美元/股，成交额2.88亿美元。消息面上，据彭博报道，私募股权巨头EQT、Advent及KKR已对快而精医药表达初步收购兴趣。事实上，早在今年1月，市场即传出快而精医药正考虑包括出售在内的多种战略选项，当时股价已因此消息一度跳涨逾10%。快而精医药是全球领先的\"样本到洞察\"解决方案提供商，在分子诊断及生命科学领域为超过50万客户提供服务，产品覆盖100多个国家。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122080761","title":"快而精医药支持邦迪布焦埃博拉病毒疫情研究与监测工作","url":"https://stock-news.laohu8.com/highlight/detail?id=1122080761","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122080761?lang=zh_cn&edition=full","pubTime":"2026-05-29 04:20","pubTimestamp":1779999657,"startTime":"0","endTime":"0","summary":"快而精医药宣布，为支持当前邦迪布焦型埃博拉病毒疫情的研究与监测工作，公司已推出两款专门定制的、仅供研究使用的QIAcuity数字PCR检测试剂。这些试剂旨在靶向与本次疫情相关的邦迪布焦埃博拉病毒基因序列。公司强调，该检测试剂仅用于研究目的，不适用于诊断程序。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2125909247.SGD","LU2433249047.HKD","BK4121","LU2125909593.SGD","QGEN","LU1923622614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161840846","title":"财报前瞻｜快而精医药本季度营收预计增1.83%，机构观点偏谨慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1161840846","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161840846?lang=zh_cn&edition=full","pubTime":"2026-01-28 10:45","pubTimestamp":1769568337,"startTime":"0","endTime":"0","summary":"快而精医药将于2026年02月04日发布最新季度财报，市场关注收入与盈利韧性及新产品周期表现。市场一致预期显示，本季度快而精医药总收入预计为5.30亿美元，同比增1.83%；EBIT预计为1.56亿美元，同比降2.57%；调整后每股收益预计为0.63美元，同比降3.97%，财务模型显示盈利端承压而收入保持温和增长，净利率与毛利率的季度预测未披露。机构普遍认为本季度收入同比增长约1.83%，但EBIT与EPS同比小幅下滑，核心关注费用投入与产品组合变化。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻｜快而精医药本季度营收预计增1.83%，机构观点偏谨慎","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512174796","title":"Baird：下调Qiagen(QGEN.US)评级，由优于大市调整至中性评级, 目标价由52.00美元调整至42.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2512174796","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512174796?lang=zh_cn&edition=full","pubTime":"2025-02-19 18:13","pubTimestamp":1739960009,"startTime":"0","endTime":"0","summary":"Baird：下调Qiagen(QGEN.US)评级，由优于大市调整至中性评级, 目标价由52.00美元调整至42.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/19181348262789.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["QGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510051839","title":"快而精医药2024财年实现净利润83.59百万美元，同比减少75.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510051839","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510051839?lang=zh_cn&edition=full","pubTime":"2025-02-09 00:00","pubTimestamp":1739030450,"startTime":"0","endTime":"0","summary":"2月9日，快而精医药公布财报，公告显示公司2024财年净利润为83.59百万美元，同比减少75.49%；其中营业收入为19.78亿美元，同比增加0.66%，每股基本收益为--。从资产负债表来看，快而精医药总负债21.22亿美元，其中短期债务53.48百万美元，资产负债比为2.69，流动比率为3.61。机构评级：截至2025年2月9日，当前有18家机构对快而精医药目标价做出预测，其中目标均价为50.36美元，其中最低目标价为45.00美元，最高目标价为55.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250209000058a23e5b6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250209000058a23e5b6a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501222235","title":"大摩：下调Qiagen评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2501222235","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501222235?lang=zh_cn&edition=full","pubTime":"2025-01-06 20:17","pubTimestamp":1736165833,"startTime":"0","endTime":"0","summary":"大摩：下调Qiagen(QGEN.US)评级，由增持调整至持股观望评级,目标价由50.00美元调整至48.00美元。快而精医药(QGEN.US)公司简介：QIAGEN NV是一家控股公司，致力于提供从样品到洞察的解决方案，使客户能够从包含生命构建块的样品中获得有价值的分子见解。该公司的样品技术从血液、组织和其他材料中分离和处理DNA、RNA和蛋白质。牢固的分析技术使这些生物分子可见并准备好进行分析。它的生物信息学软件和知识库解释数据，以报告相关的、可操作的见解。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106202540aba06b52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106202540aba06b52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2490042168","title":"快而精医药盘中异动 快速上涨5.08%报46.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490042168","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490042168?lang=zh_cn&edition=full","pubTime":"2024-12-11 02:41","pubTimestamp":1733856064,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日02时41分，快而精医药股票出现波动，股价快速拉升5.08%。截至发稿，该股报46.57美元/股，成交量73.3585万股，换手率0.33%，振幅2.41%。快而精医药股票所在的生命科学行业中，整体涨幅为0.27%。其相关个股中，Inotiv, Inc.、快而精医药、Neogenomics, Inc.涨幅较大，Applied Dna Sciences, Inc.、Inotiv, Inc.、Mainz Biomed N.V.较为活跃，换手率分别为8.30%、6.95%、2.66%，振幅较大的相关个股有Inotiv, Inc.、Applied Dna Sciences, Inc.、Mainz Biomed N.V.，振幅分别为23.03%、16.30%、15.61%。Qiagen 近 90% 的收入来自消耗品，其余收入来自仪器和相关服务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211024104984b1841&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211024104984b1841&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2125909247.SGD","QGEN","LU2433249047.HKD","LU1923622614.USD","BK4121","LU2125909593.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2483309434","title":"快而精医药2024财年第三财季实现净利润98.06百万美元，同比增加26.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483309434","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483309434?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:00","pubTimestamp":1731686425,"startTime":"0","endTime":"0","summary":"11月16日，快而精医药公布财报，公告显示公司2024财年第三财季净利润为98.06百万美元，同比增加26.01%；其中营业收入为5.02亿美元，同比增加5.46%，每股基本收益为0.44美元。从资产负债表来看，快而精医药总负债27.40亿美元，其中短期债务5.55亿美元，资产负债比为2.29，流动比率为2.18。机构评级：截至2024年11月16日，当前有18家机构对快而精医药目标价做出预测，其中目标均价为51.47美元，其中最低目标价为45.00美元，最高目标价为60.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000130abc51401&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000130abc51401&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QGEN"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.qiagen.com","stockEarnings":[{"period":"1week","weight":-0.0014},{"period":"1month","weight":0.1142},{"period":"3month","weight":0.0791},{"period":"6month","weight":-0.2548},{"period":"1year","weight":-0.2187},{"period":"ytd","weight":-0.1244}],"compareEarnings":[{"period":"1week","weight":-0.0167},{"period":"1month","weight":0.0063},{"period":"3month","weight":0.034},{"period":"6month","weight":0.071},{"period":"1year","weight":0.1639},{"period":"ytd","weight":0.0825}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Qiagen N.V.是一家成立于1984年的荷兰控股公司，其子公司是样品检验与化验技术（Sample and Assay Technologies）的主要提供者。该公司是“样本到洞察”解决方案的全球领导者，为两个广泛的客户群中的500,000多个客户提供服务：分子诊断（人类保健）和生命科学（学术界，制药研发和工业应用，主要是法医学）。公司在超过100个国家经营其产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.466667,"avgChangeRate":0.026288},{"month":2,"riseRate":0.6,"avgChangeRate":0.026915},{"month":3,"riseRate":0.366667,"avgChangeRate":0.003481},{"month":4,"riseRate":0.566667,"avgChangeRate":0.013697},{"month":5,"riseRate":0.533333,"avgChangeRate":0.020842},{"month":6,"riseRate":0.533333,"avgChangeRate":0.007096},{"month":7,"riseRate":0.645161,"avgChangeRate":0.038875},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.005901},{"month":9,"riseRate":0.366667,"avgChangeRate":-0.01054},{"month":10,"riseRate":0.433333,"avgChangeRate":0.017787},{"month":11,"riseRate":0.6,"avgChangeRate":0.034255},{"month":12,"riseRate":0.566667,"avgChangeRate":-0.000367}],"exchange":"NYSE","name":"快而精医药","nameEN":"Qiagen NV"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"快而精医药(QGEN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供快而精医药(QGEN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"快而精医药,QGEN,快而精医药股票,快而精医药股票老虎,快而精医药股票老虎国际,快而精医药行情,快而精医药股票行情,快而精医药股价,快而精医药股市,快而精医药股票价格,快而精医药股票交易,快而精医药股票购买,快而精医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"快而精医药(QGEN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供快而精医药(QGEN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}